Boehringer Ingelheim today announces the start of the THULITE Phase II clinical study (NCT06962839). It will investigate the efficacy, safety and tolerability of BI 1815368 as a potential oral ...

Breakthrough Therapy designation based on interim clinical data from Phase I/II trials showing clinically meaningful ...

New and Unprecedented Survival, Respiratory, and Biomarker Data Prove that NurOwn Helps People with ALS Live Longer and Live ...

Wave Life Sciences could offer significant upside if obesity candidate WVE-007 delivers strong human data. Check out the ...

DU UG Admission 2025: The Delhi University has announced the schedule for Phase 2 of the Common Seat Allocation System (CSAS) ...

In a major policy shift, the UAE has introduced a nomination-based Golden Visa offering lifetime residency for a one-time fee ...

Eli Lilly is a leader in the weight loss drug market, generating blockbuster revenue. Viking Therapeutics recently launched a phase 3 trial for its weight loss candidate -- and could have a promising ...

Arctic Stream SA, a Bucharest Stock Exchange-listed provider of IT infrastructure and cybersecurity integration solutions ...

These works are split into multiple phases, with the first already ongoing, and the third phase not earmarked to start in ...

Construction works has begun on six MRT stations under the second phase of the Cross Island Line (CRL), with completion ...

Construction on Phase 2 of the Cross Island Line (CRL) is officially under way in Singapore, with the Land Transport ...

Mercedes AMG set to discontinue four cylinder plug in hybrid powertrain used in the C 63 S E Performance and GLC 63 S E ...